CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

GSK PLC GSK shares advanced 1.39% to £13.91 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.85% to 9,138.37. GSK PLC ...

Q2 2025 Earnings Call Transcript July 22, 2025 Sap Se beats earnings expectations. Reported EPS is $1.7, expectations were $1 ...

GSK’s share price has fallen a lot in 10 months, which means it could be a huge bargain. I ran the key numbers and examined ...

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment, the company said on Wednesday.

Full year adjusted EPS is now expected to be $2.95 to $2.99, representing growth of 18% to 19% versus 2024, including an approximate $0.04 headwind from foreign exchange. Third quarter adjusted EPS is ...

The construction of a digital twin model for the full life cycle of rolling bearings is of great significance for analyzing their degradation performance and health management. However, existing ...

The enterprise suite introduces four key AI agents – finance, payments, accounting and project management – each designed to ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

Tapestry, Inc. (TPR) Opinions on Upcoming Investor Day and Market Performance July 11, 2025 — 01:00 pm EDT Written by Quiver DiscussionTracker for Quiver Quantitative -> ...